DK166623B1 - Terapeutisk aktive 4-phenylamino-quinolinderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne - Google Patents
Terapeutisk aktive 4-phenylamino-quinolinderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne Download PDFInfo
- Publication number
- DK166623B1 DK166623B1 DK528889A DK528889A DK166623B1 DK 166623 B1 DK166623 B1 DK 166623B1 DK 528889 A DK528889 A DK 528889A DK 528889 A DK528889 A DK 528889A DK 166623 B1 DK166623 B1 DK 166623B1
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- butyryl
- methylphenylamino
- quinoline
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8804444 | 1988-02-25 | ||
GB888804444A GB8804444D0 (en) | 1988-02-25 | 1988-02-25 | Compounds |
EP8900175 | 1989-02-20 | ||
PCT/EP1989/000175 WO1989008104A1 (en) | 1988-02-25 | 1989-02-20 | 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion |
Publications (3)
Publication Number | Publication Date |
---|---|
DK528889A DK528889A (da) | 1989-10-24 |
DK528889D0 DK528889D0 (da) | 1989-10-24 |
DK166623B1 true DK166623B1 (da) | 1993-06-21 |
Family
ID=10632376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK528889A DK166623B1 (da) | 1988-02-25 | 1989-10-24 | Terapeutisk aktive 4-phenylamino-quinolinderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne |
Country Status (22)
Country | Link |
---|---|
US (1) | US5089504A (fi) |
EP (1) | EP0330485B1 (fi) |
JP (1) | JPH0774204B2 (fi) |
KR (1) | KR0159083B1 (fi) |
CN (2) | CN1027368C (fi) |
AU (1) | AU606508B2 (fi) |
CA (1) | CA1332839C (fi) |
CZ (1) | CZ398391A3 (fi) |
DE (1) | DE68906687T2 (fi) |
DK (1) | DK166623B1 (fi) |
ES (1) | ES2055037T3 (fi) |
FI (1) | FI93952C (fi) |
GB (1) | GB8804444D0 (fi) |
HU (1) | HU208814B (fi) |
IE (1) | IE63239B1 (fi) |
IL (1) | IL89346A (fi) |
MY (1) | MY105158A (fi) |
NZ (1) | NZ228098A (fi) |
PT (1) | PT89789B (fi) |
WO (1) | WO1989008104A1 (fi) |
ZA (1) | ZA891402B (fi) |
ZW (1) | ZW1989A1 (fi) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
WO1991014677A1 (fr) * | 1990-03-28 | 1991-10-03 | Otsuka Pharmaceutical Co., Ltd. | Derive de quinoline, medicament anti-ulcereux contenant ce derive et production de ce derive |
CZ153293A3 (en) * | 1991-01-29 | 1993-12-15 | Smithkline Beecham Intercredit | Salts of 4-amino-acylquinoline derivative |
GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
SE9302005D0 (sv) | 1993-06-11 | 1993-06-11 | Ab Astra | New active compounds |
US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
WO1999061438A1 (en) * | 1998-05-23 | 1999-12-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
AU2002342917A1 (en) * | 2001-11-19 | 2003-06-10 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
JP4634144B2 (ja) | 2002-08-01 | 2011-02-16 | ニコックス エスエー | ニトロソ化プロトンポンプ阻害剤、組成物および使用方法 |
ME00524B (me) | 2003-03-10 | 2011-10-10 | Astrazeneca Ab | Novi postupak za dobijanje roflumilasta |
CN1874772A (zh) | 2003-11-03 | 2006-12-06 | 阿斯利康(瑞典)有限公司 | 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物 |
WO2006097456A1 (en) * | 2005-03-16 | 2006-09-21 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
CN106496119A (zh) * | 2016-10-17 | 2017-03-15 | 江南大学 | 一种n‑苯基‑8‑氨基喹啉的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2652398A (en) * | 1949-11-17 | 1953-09-15 | Endo Products Inc | N-substituted-2-amino (methyl) quinolines |
US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
CA942748A (en) * | 1970-09-18 | 1974-02-26 | Venkatachala L. Narayanan | 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds |
ZA801526B (en) * | 1979-03-26 | 1981-08-26 | Robins Co Inc A H | 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds |
US4343804A (en) * | 1979-03-26 | 1982-08-10 | A. H. Robins Company, Inc. | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
-
1988
- 1988-02-25 GB GB888804444A patent/GB8804444D0/en active Pending
-
1989
- 1989-02-20 HU HU891463A patent/HU208814B/hu not_active IP Right Cessation
- 1989-02-20 JP JP1502451A patent/JPH0774204B2/ja not_active Expired - Lifetime
- 1989-02-20 AU AU31819/89A patent/AU606508B2/en not_active Ceased
- 1989-02-20 ZW ZW19/89A patent/ZW1989A1/xx unknown
- 1989-02-20 KR KR1019890701954A patent/KR0159083B1/ko not_active IP Right Cessation
- 1989-02-20 IL IL8934689A patent/IL89346A/en not_active IP Right Cessation
- 1989-02-20 WO PCT/EP1989/000175 patent/WO1989008104A1/en active IP Right Grant
- 1989-02-21 CA CA000591638A patent/CA1332839C/en not_active Expired - Fee Related
- 1989-02-21 MY MYPI89000210A patent/MY105158A/en unknown
- 1989-02-22 NZ NZ228098A patent/NZ228098A/xx unknown
- 1989-02-22 PT PT89789A patent/PT89789B/pt not_active IP Right Cessation
- 1989-02-23 DE DE89301804T patent/DE68906687T2/de not_active Expired - Fee Related
- 1989-02-23 IE IE56889A patent/IE63239B1/en not_active IP Right Cessation
- 1989-02-23 EP EP89301804A patent/EP0330485B1/en not_active Expired - Lifetime
- 1989-02-23 ZA ZA891402A patent/ZA891402B/xx unknown
- 1989-02-23 US US07/314,726 patent/US5089504A/en not_active Expired - Lifetime
- 1989-02-23 ES ES89301804T patent/ES2055037T3/es not_active Expired - Lifetime
- 1989-02-24 CN CN89100929A patent/CN1027368C/zh not_active Expired - Fee Related
- 1989-10-24 FI FI895048A patent/FI93952C/fi not_active IP Right Cessation
- 1989-10-24 DK DK528889A patent/DK166623B1/da not_active IP Right Cessation
-
1991
- 1991-12-20 CZ CS913983A patent/CZ398391A3/cs unknown
-
1994
- 1994-02-26 CN CN94102353A patent/CN1100414A/zh active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK166623B1 (da) | Terapeutisk aktive 4-phenylamino-quinolinderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne | |
US4017622A (en) | Piperazine derivatives | |
AU643337B2 (en) | Condensed heterocyclic compounds, their production and use | |
DK173057B1 (da) | 5-Alkyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridinforbindelser, fremgangsmåder til fremstilling deraf, farmaceutisk præpara | |
DK159308B (da) | 4-aminoquinolinderivater, farmaceutisk middel der indeholder disse samt anvendelse af disse til fremstilling af et laegemiddel | |
AU659027B2 (en) | Substituted thienyl- or pyrrolylcarboxyclic acid derivatives, their preparation and medicines containing them | |
KR20010085856A (ko) | 단백질 티로신 키나제 억제제로서 치환된 3-시아노퀴놀린 | |
NO894228L (no) | Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater. | |
DK2364298T3 (en) | Quinolone AND PHARMACEUTICAL COMPOSITION | |
NO178149B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 7-tetrahydro-naftyridin-6-fluor-1,4-dihydro-4-okso-kinolin-3-karboksylsyrer | |
JP2006511519A (ja) | 血小板アデノシン二リン酸受容体アンタゴニストとしての2−アミノカルボニルキノリン化合物 | |
CZ20013660A3 (cs) | Substituované 3-kyano-(1,7),(1,5) a (1,8)-naftyridinové inhibitory tyrosinových kináz | |
US5006535A (en) | Substituted heterocylic 4-aminoquinoline derivatives as gastric acid secretion inhibitors | |
US5089498A (en) | Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors | |
EP0416749B1 (en) | Substituted 4-aminoquinolines | |
RU2142454C1 (ru) | Производные 4-амино-3-ацилхинолина, способ их получения, фармацевтический препарат на их основе, способ получения фармацевтического препарата и промежуточное соединение | |
US5082848A (en) | Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors | |
US5432182A (en) | Compounds substituted quinoline derivatives | |
US5049567A (en) | Substituted 4-aminoquinazoline derivatives and method of use | |
IL106072A (en) | Intermediates for the preparation of 4-aminoquinolines | |
NO176712B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-amino-3-acylkinolinderivater | |
NO894189L (no) | 4-amino-3-acylkinolonderivater og deres anvendelse som inhibitorer av mavesyresekresjon. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |